Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer

World Journal of Urology

Volumn 33, Issue 7, 2015, Pages 1015-1021

  Rud, Erik ^a   Klotz, Dagmar ^a   Rennesund, Kristin ^a   Baco, Eduard ^a   Johansen, Truls Erik Bjerklund ^a   Diep, Lien My ^a   Svindland, Aud ^a   Eri, Lars Magne ^a   Eggesbø, Heidi B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Accuracy; Extraprostatic disease; MRI; Prostate cancer; Staging

Indexed keywords

ADULT; AGED; CANCER STAGING; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84933183293     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1362-x     Document Type: Article

References (24)

1. Obek C, Louis P, Civantos F, Soloway MS (1999) Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. JURO 161:494–8, discussion 498–9
2. Flanigan RC, Catalona WJ, Richie JP et al (1994) Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. JURO 152:1506–1509
3. Delongchamps NB, Rouanne M, Flam T et al (2010) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418
4. Hegde JV, Chen MH, Mulkern RV et al (2013) Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 85:101–107
5. Somford DM, Hamoen EH, Fütterer JJ et al (2013) The predictive value of endorectal 3 tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol 190:1728–1734
6. Brajtbord JS, Lavery HJ, Nabizada-Pace F et al (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107:1419–1424
7. Rosenkrantz AB, Chandarana H, Gilet A et al (2013) Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension. J Magn Reson Imaging 38:312–319
8. Kim B, Breau RH, Papadatos D et al (2010) Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. Can Urol Assoc J 4:257–262
9. Graser A, Heuck A, Sommer B et al (2007) Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. Am J Roentgenol 188:84–90
10. Hricak H, Choyke PL, Eberhardt SC et al (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53
11. Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumor and tumor volume in prostate cancer using T2w and DW MRI alone. BJU Int. doi:10.1111/bju.12637
12. Cornud F, Rouanne M, Beuvon F et al (2011) Endorectal 3D T2-weighted 1 mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria?. Eur J Radiol 1–7
13. Osunkoya AO (2012) Update on prostate pathology. Pathology 44:391–406
14. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757
15. Magi-Galluzzi C, Evans AJ, Delahunt B et al (2010) International society of urological pathology (isup) consensus conference on handling and staging of radical prostatectomy specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 24:26–38
16. Berney DM, Wheeler TM, Grignon DJ et al (2010) International society of urological pathology (isup) consensus conference on handling and staging of radical prostatectomy specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 24:39–47
17. D’Amico AV, Whittington R, Malkowicz SB et al (2001) Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 166:2185–2188
18. McClure TD, Margolis DJA, Reiter RE et al (2012) Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy. Radiology 262:874–883
19. Hricak H, Wang L, Wei DC et al (2004) The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100:2655–2663
20. Roethke MC, Lichy MP, Kniess M et al (2012) Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol
21. Brown JA, Rodin DM, Harisinghani M, Dahl DM (2010) Impact of preoperative endorectal MRI stage classification on neurovascular bundle sparing aggressiveness and the radical prostatectomy positive margin rate. URO 27:174–179
22. Gupta RT, Faridi KF, Singh AA et al (2014) Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urol Oncol. doi:10.1016/j.urolonc.2014.04.017
23. Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065
24. van der Kwast TH, Amin MB, Billis A et al (2007) Urological Pathology (ISUP) Consensus conference on handling and staging of radical prostatectomy specimens. working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24:16–25